Ferdinand Ploner Selected Research

exemestane (Aromasin)

11/2008

Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ferdinand Ploner Research Topics

Disease

5	Sarcoma (Soft Tissue Sarcoma) 02/2015 - 06/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2011 - 01/2006
5	Breast Neoplasms (Breast Cancer) 07/2009 - 10/2002
4	Neoplasms (Cancer) 02/2014 - 01/2009
2	Neoplasm Metastasis (Metastasis) 02/2014 - 04/2008
2	Anemia 01/2014 - 04/2008
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2013 - 01/2009
2	Colorectal Neoplasms (Colorectal Cancer) 11/2008 - 09/2008
1	Leiomyosarcoma 08/2014
1	Adenocarcinoma 05/2011
1	Carcinoma (Carcinomatosis) 05/2011
1	Neuroendocrine Carcinoma 05/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2011
1	Hyperthermia 06/2010
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2008
1	Liver Diseases (Liver Disease) 04/2008
1	Thrombocytopenia (Thrombopenia) 04/2008
1	Neutropenia 04/2008
1	Bronchial Neoplasms 01/2007
1	Hearing Loss (Hearing Impairment) 01/2006
1	Vomiting 01/2006
1	Acute Kidney Injury (Acute Renal Failure) 01/2006
1	Nausea 01/2006
1	Microsatellite Instability 10/2002

Drug/Important Bio-Agent (IBA)

2	Gefitinib (Iressa)FDA Link 05/2011 - 09/2010
2	Tyrosine Kinase InhibitorsIBA 05/2011 - 09/2010
2	ErbB Receptors (EGF Receptor)IBA 05/2011 - 09/2010
2	Ifosfamide FDA LinkGeneric 06/2010 - 04/2008
2	Etoposide (VP 16)FDA LinkGeneric 06/2010 - 04/2008
2	Estrogen ReceptorsIBA 07/2009 - 12/2006
1	Uric Acid (Urate)IBA 02/2015
1	Sorafenib (BAY 43-9006)FDA Link 08/2014
1	Fibrinogen (Factor I)FDA Link 02/2014
1	Hemoglobins (Hemoglobin)IBA 01/2014
1	Growth Factor ReceptorsIBA 05/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2010
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 07/2009
1	Imatinib Mesylate (Gleevec)FDA Link 01/2009
1	exemestane (Aromasin)FDA Link 11/2008
1	Hormones (Hormone)IBA 11/2008
1	Aromatase InhibitorsIBA 11/2008
1	Zoledronic Acid (Zometa)FDA Link 09/2008
1	Tamoxifen FDA LinkGeneric 09/2008
1	Anastrozole (Arimidex)FDA LinkGeneric 09/2008
1	Goserelin (Zoladex)FDA Link 09/2008
1	Carboplatin (JM8)FDA LinkGeneric 04/2008
1	IceIBA 04/2008
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2008
1	Estrogen Receptor Modulators (Antiestrogen)IBA 12/2006
1	EnzymesIBA 01/2006
1	Cisplatin (Platino)FDA LinkGeneric 01/2006
1	polyacrylamideIBA 10/2002

Therapy/Procedure

11	Therapeutics 03/2013 - 10/2002
2	Aftercare (After-Treatment) 03/2013 - 01/2009
2	Drug Therapy (Chemotherapy) 06/2010 - 07/2009
1	Time-to-Treatment 08/2014
1	Combined Modality Therapy 02/2012
1	Adjuvant Chemotherapy 06/2010
1	Neoadjuvant Therapy 11/2008
1	Mastectomy (Mammectomy) 10/2002